Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells

Oncotarget(2020)10.18632/oncotarget.27697Source: DataRank Database

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells is a research paper published in Oncotarget (2020). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.25)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Sora Lee ORCID,Jingbo Qiao,Dai H. Chung ORCID,Rachael A. Clark ORCID

Live enrichment

PubMed:32850011 PMC:PMC7429182 OpenAlex:https://openalex.org/W3048862463

NIDDK NIH HHS

Grant: R01 DK061470

NCI NIH HHS

Grant: T32 CA136515

FWCI

0.25

Citation Percentile

0.6%

Citation Trend

2022

goldLicense: cc-by

journalhttps://www.oncotarget.com/article/27697/pdf/

publisherhttps://www.oncotarget.com/article/27697/pdf/

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.27697

journalhttps://doi.org/10.18632/oncotarget.27697

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32850011

Fields of Study

Neuroblastoma Research and TreatmentsVitamin C and Antioxidants ResearchCancer, Hypoxia, and Metabolism

Keywords

NeuroblastomaPharmacologyMedicineIn vivoApoptosisMethotrexateCancer researchFlow cytometryChemotherapyCell cycleCell cultureImmunologyInternal medicineBiologyCancerBiochemistryn-mycPralatrexateFolate Metabolism

Sustainable Development Goals

SDG 0: Good health and well-being

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells

FAIR Checklist

Authors (4)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)